Hodgkin's Lymphoma Tissue Array, 45 Cases/80 Cores, Replacing HL801|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173272

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Hodgkin's Lymphoma Tissue Array, 45 Cases/80 Cores, Replacing HL801)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月16日 19時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Hodgkin's lymphoma tissue array, 45 cases/80 cores, replacing HL801
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年05月16日 19時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Hodgkin's lymphoma tissue array, 45 cases/80 cores, replacing HL801

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Hodgkin's lymphoma tumor tissue microarray, containing 27 cases of Hodgkin's lymphoma, 4 large B-cell lymphoma, 1 B large non-cleaved cell lymphoma, 3 B small cleaved cell lymphoma (duplicate cores per case), 10 normal lymph node tissue (single core per case)
Cores: 80
組織アレイ
Cases: 45
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Type †
A1 1 F 37 Mediastinum Lymphocyte depletion Hodgkin's lymphoma Malignant
A2 2 F 37 Mediastinum Lymphocyte depletion Hodgkin's lymphoma Malignant
A3 3 F 22 Lung Mixed cellularity Hodgkin's lymphoma Malignant
A4 4 F 22 Lung Mixed cellularity Hodgkin's lymphoma Malignant
A5 5 M 18 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
A6 6 M 18 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
A7 7 M 17 Lymph node Mixed cellularity Hodgkin's lymphoma of left neck Malignant
A8 8 M 17 Lymph node Mixed cellularity Hodgkin's lymphoma of left neck Malignant
A9 9 M 47 Spleen Lymphocyte depletion Hodgkin's lymphoma Malignant
A10 10 M 47 Spleen Lymphocyte depletion Hodgkin's lymphoma Malignant
B1 11 F 27 Mediastinum Lymphocyte depletion Hodgkin's lymphoma Malignant
B2 12 F 27 Mediastinum Lymphocyte depletion Hodgkin's lymphoma Malignant
B3 13 F 31 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left clavicle Malignant
B4 14 F 31 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left clavicle Malignant
B5 15 M 32 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left neck Malignant
B6 16 M 32 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left neck Malignant
B7 17 M 27 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
B8 18 M 27 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
B9 19 F 42 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
B10 20 F 42 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
C1 21 M 36 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
C2 22 M 36 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left groin Malignant
C3 23 M 26 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left armpit Malignant
C4 24 M 26 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left armpit Malignant
C5 25 M 68 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left parotid gland Malignant
C6 26 M 68 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left parotid gland Malignant
C7 27 M 18 Lymph node Lymphocyte predominance Hodgkin's lymphoma of right oxter Malignant
C8 28 M 18 Lymph node Lymphocyte predominance Hodgkin's lymphoma of right oxter Malignant
C9 29 M 50 Lymph node Mixed cellularity Hodgkin's lymphoma of right oxter Malignant
C10 30 M 50 Lymph node Mixed cellularity Hodgkin's lymphoma of right oxter Malignant
D1 31 M 41 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
D2 32 M 41 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
D3 33 M 37 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
D4 34 M 37 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
D5 35 M 36 Lymph node Lymphocyte depletion Hodgkin's lymphoma of right armpit Malignant
D6 36 M 36 Lymph node Lymphocyte depletion Hodgkin's lymphoma of right armpit Malignant
D7 37 M 51 Tongue Mixed cellularity Hodgkin's lymphoma of right submaxillary Malignant
D8 38 M 51 Tongue Mixed cellularity Hodgkin's lymphoma of right submaxillary Malignant
D9 39 M 68 Colon Lymphocyte depletion Hodgkin's lymphoma of ileocecal Malignant
D10 40 M 68 Colon Lymphocyte depletion Hodgkin's lymphoma of ileocecal Malignant
E1 41 M 35 Lymph node Lymphocyte depletion Hodgkin's lymphoma of left neck Malignant
E2 42 M 35 Lymph node Lymphocyte depletion Hodgkin's lymphoma of left neck Malignant
E3 43 M 27 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
E4 44 M 27 Lymph node Lymphocyte predominance Hodgkin's lymphoma of neck Malignant
E5 45 F 37 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
E6 46 F 37 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
E7 47 M 34 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
E8 48 M 34 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
E9 49 F 33 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left neck Malignant
E10 50 F 33 Lymph node Lymphocyte predominance Hodgkin's lymphoma of left neck Malignant
F1 51 M 24 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
F2 52 M 24 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
F3 53 M 3 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
F4 54 M 3 Lymph node Mixed cellularity Hodgkin's lymphoma of neck Malignant
F5 55 M 52 Lymph node Large B-cell lymphoma of right groin Malignant
F6 56 M 52 Lymph node Large B-cell lymphoma of right groin Malignant
F7 57 F 62 Lymph node Large B-cell lymphoma of right armpit Malignant
F8 58 F 62 Lymph node Large B-cell lymphoma of right armpit Malignant
F9 59 M 39 Lymph node Large B-cell lymphoma of right groin Malignant
F10 60 M 39 Lymph node Large B-cell lymphoma of right groin Malignant
G1 61 F 40 Lymph node Large B-cell lymphoma of right oxter Malignant
G2 62 F 40 Lymph node Large B-cell lymphoma of right oxter Malignant
G3 63 M 51 Retroperitoneum B large non-cleaved cell lymphoma Malignant
G4 64 M 51 Retroperitoneum B large non-cleaved cell lymphoma Malignant
G5 65 F 44 Colon B small cleaved cell lymphoma Malignant
G6 66 F 44 Colon B small cleaved cell lymphoma Malignant
G7 67 M 76 Colon B small cleaved cell lymphoma Malignant
G8 68 M 76 Colon B small cleaved cell lymphoma Malignant
G9 69 F 38 Breast B small cleaved cell lymphoma Malignant
G10 70 F 38 Breast B small cleaved cell lymphoma Malignant
H1 71 M 68 Stomach Cancer adjacent normal lymph node tissue NAT
H2 72 F 42 Breast Cancer adjacent normal lymph node tissue NAT
H3 73 M 71 Larynx Cancer adjacent normal lymph node tissue NAT
H4 74 M 69 Stomach Cancer adjacent normal lymph node tissue NAT
H5 75 F 57 Breast Cancer adjacent normal lymph node tissue NAT
H6 76 M 53 Intestine Cancer adjacent normal lymph node tissue NAT
H7 77 M 44 Cardia Cancer adjacent normal lymph node tissue NAT
H8 78 M 42 Rectum Cancer adjacent normal lymph node tissue NAT
H9 79 F 51 Tongue Cancer adjacent normal lymph node tissue NAT
H10 80 M 43 Lymph node Normal lymph node tissue Normal
M 42 Adrenal gland Pheochromocytoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。